DE60106968D1 - Kombination von gaba agonisten und sorbitol dehydrogenase inhibitoren - Google Patents

Kombination von gaba agonisten und sorbitol dehydrogenase inhibitoren

Info

Publication number
DE60106968D1
DE60106968D1 DE60106968T DE60106968T DE60106968D1 DE 60106968 D1 DE60106968 D1 DE 60106968D1 DE 60106968 T DE60106968 T DE 60106968T DE 60106968 T DE60106968 T DE 60106968T DE 60106968 D1 DE60106968 D1 DE 60106968D1
Authority
DE
Germany
Prior art keywords
combination
dehydrogenase inhibitors
sorbitol dehydrogenase
gaba agonists
gaba
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60106968T
Other languages
English (en)
Other versions
DE60106968T2 (de
Inventor
Banavara Lakshman Mylari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Publication of DE60106968D1 publication Critical patent/DE60106968D1/de
Application granted granted Critical
Publication of DE60106968T2 publication Critical patent/DE60106968T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60106968T 2000-11-30 2001-11-19 Kombination von gaba agonisten und sorbitol dehydrogenase inhibitoren Expired - Fee Related DE60106968T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25006900P 2000-11-30 2000-11-30
US250069P 2000-11-30
PCT/IB2001/002213 WO2002043762A2 (en) 2000-11-30 2001-11-19 Combination of gaba agonists and sorbitol dehydrogenase inhibitors

Publications (2)

Publication Number Publication Date
DE60106968D1 true DE60106968D1 (de) 2004-12-09
DE60106968T2 DE60106968T2 (de) 2005-11-03

Family

ID=22946187

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60106968T Expired - Fee Related DE60106968T2 (de) 2000-11-30 2001-11-19 Kombination von gaba agonisten und sorbitol dehydrogenase inhibitoren

Country Status (38)

Country Link
US (1) US6544998B2 (de)
EP (1) EP1337271B1 (de)
JP (1) JP2004514699A (de)
KR (1) KR20030059290A (de)
CN (1) CN1477975A (de)
AP (1) AP2001002360A0 (de)
AR (1) AR031431A1 (de)
AT (1) ATE281181T1 (de)
AU (1) AU2002215159A1 (de)
BG (1) BG107774A (de)
BR (1) BR0115783A (de)
CA (1) CA2430298A1 (de)
CR (1) CR6964A (de)
CZ (1) CZ20031399A3 (de)
DE (1) DE60106968T2 (de)
DO (1) DOP2001000289A (de)
EA (1) EA200300432A1 (de)
EC (1) ECSP034624A (de)
EE (1) EE200300248A (de)
ES (1) ES2230378T3 (de)
HR (1) HRP20030420A2 (de)
HU (1) HUP0302160A3 (de)
IL (1) IL155704A0 (de)
IS (1) IS6786A (de)
MA (1) MA26964A1 (de)
MX (1) MXPA03004870A (de)
NO (1) NO20032441L (de)
OA (1) OA12534A (de)
PA (1) PA8534101A1 (de)
PE (1) PE20020597A1 (de)
PL (1) PL365927A1 (de)
PT (1) PT1337271E (de)
SK (1) SK6192003A3 (de)
SV (1) SV2003000751A (de)
TN (1) TNSN01169A1 (de)
UY (1) UY27042A1 (de)
WO (1) WO2002043762A2 (de)
ZA (1) ZA200303381B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100491282B1 (ko) 1996-07-24 2005-05-24 워너-램버트 캄파니 엘엘씨 통증 치료용 이소부틸가바 및 그의 유도체
US6992109B1 (en) * 1999-04-08 2006-01-31 Segal Catherine A Method for the treatment of incontinence
US7022678B2 (en) * 2001-03-30 2006-04-04 Warner-Lambert Company Pregabalin lactose conjugates
SK286227B6 (sk) * 2001-05-25 2008-05-06 Warner-Lambert Company Llc Kvapalná farmaceutická kompozícia obsahujúca analóg GABA a spôsob jej prípravy a použitie
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
KR20050036195A (ko) * 2003-10-15 2005-04-20 고재영 신규한 망막병증 치료제 조성물
US8007827B2 (en) * 2004-04-02 2011-08-30 Impax Laboratories, Inc. Pharmaceutical dosage forms having immediate release and/or controlled release properties
CA2560995A1 (en) * 2004-04-02 2005-10-20 Impax Laboratories, Inc. Controlled release dosage for gaba receptor agonist
US20050220873A1 (en) * 2004-04-02 2005-10-06 Chien-Hsuan Han Pharmaceutical dosage forms having immediate and controlled release properties that contain a GABAB receptor agonist
US20050226927A1 (en) * 2004-04-02 2005-10-13 Impax Laboratories, Inc. Pharmaceutical dosage forms having immediate release and/or controlled release properties that contain a GABAB receptor agonist
GB0420831D0 (en) 2004-09-17 2004-10-20 Glaxo Group Ltd Novel compounds
ES2528674T3 (es) 2005-02-17 2015-02-11 Astellas Pharma Inc. Piperidina y carboxilatos de piperacina como inhibidores de FAAH
GB0513553D0 (en) * 2005-07-01 2005-08-10 Fond D Amico Per La Ricerca Su Rab3a
DK2142529T3 (da) 2007-04-27 2014-02-10 Purdue Pharma Lp Trpv1-antagonister og anvendelser deraf
JP5452494B2 (ja) * 2007-10-09 2014-03-26 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング ベンフォチアミンと１または２種以上の医薬活性剤とを含む神経因性の疼痛状態の処置のための医薬組成物
SG176464A1 (en) 2008-05-09 2011-12-29 Agency Science Tech & Res Diagnosis and treatment of kawasaki disease
JP5815552B2 (ja) 2009-12-08 2015-11-17 ケース ウェスタン リザーブ ユニバーシティＣａｓｅ Ｗｅｓｔｅｒｎｒｅｓｅｒｖｅ Ｕｎｉｖｅｒｓｉｔｙ 眼疾患を治療する化合物および方法
DK2621282T3 (da) * 2010-09-28 2020-05-04 Univ California Gaba-agonister i behandlingen af forstyrrelser forbundet med metabolisk syndrom og gaba-kombinationer i behandling eller profylakse af type i diabetes
CA2837178C (en) 2011-06-22 2016-09-20 Purdue Pharma L.P. Trpv1 antagonists including dihydroxy substituent and uses thereof
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
EP3955936A1 (de) 2019-04-17 2022-02-23 COMPASS Pathfinder Limited Behandlung von depression und anderen verschiedenen störungen mit psilocybin
JP2022531466A (ja) * 2019-05-07 2022-07-06 ユニバーシティ オブ マイアミ 遺伝性ニューロパチーおよび関連障害の処置および検出

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2409754A (en) 1946-10-22 Method for obtaining hydantoins
CH449645A (de) 1963-07-09 1968-01-15 Ciba Geigy Verfahren zur Herstellung neuer Aminosäuren
CH427803A (de) 1963-12-06 1967-01-15 Geigy Ag J R Verfahren zur Herstellung eines neuen Isoxazolderivates
DE2460891C2 (de) * 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US3960927A (en) 1975-03-18 1976-06-01 Richardson-Merrell Inc. Olefinic derivatives of amino acids
FR2319338A1 (fr) * 1975-08-01 1977-02-25 Synthelabo Nouveaux derives de a- phenyl benzylideniques des acides amines, leur preparation et les medicaments qui en contiennent
DK153787C (da) 1979-06-01 1989-01-16 Wellcome Found Analogifremgangsmaade til fremstilling af substituerede 3,5-diamino-6-phenyl-1,2,4-triaziner og alfa-cyanobenzyliden-aminoguanidinforbindelser til anvendelse som mellemprodukter herved
FR2492258A1 (fr) * 1980-10-17 1982-04-23 Pharmindustrie Nouveau medicament a base d'amino-2 trifluoromethoxy-6 benzothiazole
US4513006A (en) 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
DK288385D0 (da) 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
US6197819B1 (en) 1990-11-27 2001-03-06 Northwestern University Gamma amino butyric acid analogs and optical isomers
KR950703539A (ko) * 1992-09-28 1995-09-20 알렌 제이. 스피겔 당뇨병 합병증 치료용 치환된 피리미딘(substituted pyrimidines for control or diabetic complications)
AU3503300A (en) * 1999-02-24 2000-09-14 Regents Of The University Of California, The Gaba receptors mediate inhibition of t cell responses
DE60009777T2 (de) * 1999-04-01 2004-08-19 Pfizer Products Inc., Groton Verbindung für Behandlung und Vorsorge bei Diabetes
EP1185275A1 (de) * 1999-04-01 2002-03-13 Pfizer Products Inc. Aminopyrimidine als sorbitdehydrogenasehemmer

Also Published As

Publication number Publication date
NO20032441D0 (no) 2003-05-28
BG107774A (en) 2004-01-30
CZ20031399A3 (cs) 2004-04-14
SK6192003A3 (en) 2004-07-07
PA8534101A1 (es) 2002-10-31
HRP20030420A2 (en) 2004-08-31
ZA200303381B (en) 2004-04-30
MA26964A1 (fr) 2004-12-20
PE20020597A1 (es) 2002-07-08
KR20030059290A (ko) 2003-07-07
IL155704A0 (en) 2003-11-23
CR6964A (es) 2004-02-02
CN1477975A (zh) 2004-02-25
HUP0302160A3 (en) 2005-05-30
SV2003000751A (es) 2003-01-13
AP2001002360A0 (en) 2001-12-31
US20020091128A1 (en) 2002-07-11
AR031431A1 (es) 2003-09-24
OA12534A (en) 2006-06-05
WO2002043762A3 (en) 2003-03-13
EP1337271B1 (de) 2004-11-03
WO2002043762A2 (en) 2002-06-06
PL365927A1 (en) 2005-01-10
MXPA03004870A (es) 2003-08-19
ATE281181T1 (de) 2004-11-15
IS6786A (is) 2003-04-14
EA200300432A1 (ru) 2003-10-30
BR0115783A (pt) 2003-09-16
ECSP034624A (es) 2003-07-25
EE200300248A (et) 2003-10-15
US6544998B2 (en) 2003-04-08
TNSN01169A1 (fr) 2005-11-10
EP1337271A2 (de) 2003-08-27
HUP0302160A2 (hu) 2003-11-28
PT1337271E (pt) 2005-01-31
UY27042A1 (es) 2002-07-31
ES2230378T3 (es) 2005-05-01
CA2430298A1 (en) 2002-06-06
DOP2001000289A (es) 2003-02-15
DE60106968T2 (de) 2005-11-03
NO20032441L (no) 2003-07-03
AU2002215159A1 (en) 2002-06-11
JP2004514699A (ja) 2004-05-20

Similar Documents

Publication Publication Date Title
ATE281181T1 (de) Kombination von gaba agonisten und sorbitol dehydrogenase inhibitoren
CY2015053I2 (el) Υδροξαμικα παραγωγα χρησιμα ως αναστολεις δεακετυλασης
DE60221977D1 (de) Pro-pharmakon von cox-2-inhibitoren
AR028253A1 (es) Inhibidores de la glucogeno fosforilasa
IS6934A (is) Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar
NO20032668L (no) Gyraseinhibitorer og anvendelser derav
CY2012007I1 (el) Πεπτιδομιμητικοι αναστολεις πρωτεασης
EE200300249A (et) GABA agonistide ja aldoosreduktaasi inhibiitoritekombinatsioon
NO20026283L (no) Inhibitorer av kobberholdige aminosydaser
NO20042229L (no) Type 4-fosfodiestemseinhibitorer og anvendelse derav
DE60135087D1 (de) Dipeptidnitrile als inhibitoren von cathepsin k
EE200300134A (et) Uued tiadiasoolid ja oksadiasoolid ning nende kasutamine fosfodiesteraas-7 inhibiitoritena
ID30590A (id) Celana sekali pakai jenis-celana pendek
NO20005265L (no) Substituerte benzamider, deres fremstilling og anvendelse som inhibitorer av cystin-proteaser
NO20024528L (no) Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen
GB0025782D0 (en) Use of inhibitors
DK1307263T3 (da) Hidtil ukendt anvendelse af lipaseinhibitorer
EP1448218A4 (de) Beta-secretase-hemmer und anwendungsverfahren
DE60221798D1 (de) Kombinationen von gallensäuresequestriermitteln und hemmern der sterolabsorption zur behandlung von kardiovaskulären indikationen
DK1272488T3 (da) Tri-aryl-substitueret ethan-PDE4-inhibitorer
NO20025005L (no) Proteaseinhibitorer
DK1130214T3 (da) Korrosionsinhibitorer
DE60106740D1 (de) Hydrazid und alkoxyamid angiogeneseinhibitoren
DE60124397D1 (de) Inhibitoren von serinproteasen
AU1212002A (en) Use of lipase inhibitors

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee